5 completed. 5 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Completed 5 |
Follow VX-809: new trials by email Literature Review of VX-809 trials Research Report on VX-809
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 1 Study to Investigate the Food Effect of Lumacaftor in Combination With Ivacaftor lumacaftor, ivacaftor - Cystic Fibrosis | Phase 1 | Completed | Vertex Pharmaceuticals Incorporated | 28 | 2013-07-01 | 2014-04-03 |
| Phase 1, QT/QTC Interval Study in Healthy Subjects Lumacaftor, Lumacaftor Placebo, Ivacaftor - Cystic Fibrosis | Phase 1 | Completed | Vertex Pharmaceuticals Incorporated | 200 | 2013-06-01 | 2014-08-11 |
| A Phase 1 Study to Examine the Drug-Drug Interaction of Ciprofloxacin, Itraconazole, and Rifampin on the Combination of Lumacaftor With Ivacaftor in Healthy Adult Subjects Lumacaftor, Ivacaftor, Ciprofloxacin - Cystic Fibrosis | Phase 1 | Completed | Vertex Pharmaceuticals Incorporated | 80 | 2013-01-01 | 2013-11-15 |
| Drug-Drug Interaction Study of VX-770 and VX-809 in Healthy Subjects VX-809, VX-770, VX-809 placebo - Cystic Fibrosis | Phase 1 | Completed | Vertex Pharmaceuticals Incorporated | 48 | 2010-10-01 | 2012-01-18 |
| Drug-Drug Interaction Study of VX-809 and VX-770 in Healthy Subjects VX-809, VX-770, VX-809 & VX-770 - Cystic Fibrosis | Phase 1 | Completed | Vertex Pharmaceuticals Incorporated | 24 | 2009-09-01 | 2010-01-05 |
Cystic Fibrosis (5)
Vertex Pharmaceuticals Incorporated (5)
United States (3) · Netherlands (2)
Laurent Vernillet, PharmD, PhD, FCP (1)